Big Tech and the Banks Take Center Stage in a Blockbuster Earnings Week
The week ahead is stacked with heavyweights, and all eyes will be on the megacap names that move markets. Tesla $TSLA and Alphabet $GOOGL headline a crowded slate on the same July day, and the mood around both is decidedly upbeat—Tesla in particular is entering the print riding a wave of optimism and improving underlying trends, though anyone chasing the stock should brace for the outsized swings that have become its calling card. Intel $INTC and Texas Instruments $TXN round out a semiconductor-heavy narrative where the bulls have the upper hand; both look strong going in, and TI especially has quietly built momentum that could reward the faithful. ServiceNow $NOW and IBM $IBM will test whether enterprise software and legacy tech can keep delivering, but the tone there is more cautious, with skeptics circling ServiceNow despite a healthy setup. Options desks are pricing in especially dramatic reactions from the likes of MaxLinear, United Rentals, and Medpace, so traders looking for fireworks won't have to look far.
The financial sector arrives in force, with a parade of banks and insurers led by American Express $AXP, Capital One $COF, Charles Schwab $SCHW, Chubb $CB and Moody's $CBO. Sentiment across the group skews constructive, and names like Zions $ZION, East West Bancorp and Interactive Brokers are drawing quiet confidence heading into their reports. Elsewhere, the industrial and transport complex—CSX $CNX, Canadian National $CNI, RTX $RTX and GE Vernova $GEV —looks poised to benefit from steady tailwinds, while GE Vernova's energy-adjacent story remains a standout for the bulls. Not everyone is walking in with the wind at their back, though: Domino's $DPZ, Charter Communications $CHTR, Comcast $CMCSA and Lamb Weston $LW face real skepticism, with consumer-facing and media names carrying the heaviest doubts. Airlines add a wildcard, as American $AAL, Southwest $LUV and Alaska $ALK each try to convince investors the recovery narrative still has legs. In a week this dense, expect the surprises to come as much from the overlooked mid-caps as from the household names everyone is watching.
Nokia's AI/Cloud Engine Fires as NI Guidance Steps Up
Nokia (NOK) reports Thursday, July 23, 2026 before the open, with the Street looking for $0.07 per share on $5.59 billion in revenue — 8.4% year-over-year growth — while the Earnings Whisper number sits a penny higher at $0.08. Sentiment is constructive, with 71.1% of investors expecting a beat and overall estimates revised higher since last quarter, even as short interest has climbed 8.6%. The stock has drifted 6.1% lower since its post-earnings open but still sits 13.4% above its $8.92 200-day moving average. Options are pricing a 13.0% move versus a 7.0% average in recent quarters, and on Tuesday, July 14, traders scooped up 43,045 of the $12.00 calls expiring August 21 — a decidedly bullish bet.
The key read into this print is whether Q1's inflection has legs. Last quarter management delivered its first hard guidance raise in four calls, lifting FY26 network infrastructure growth to 12-14% (from 6-8%) and optical+IP to 18-20% (from 10-12%) on the back of EUR1bn in new AI & cloud orders at a ~3x book-to-bill and 49% AI/cloud sales growth. Watch for IP networks to finally convert design wins into orders from Q2 onward, and for Infinera synergies and gross margin (45.5% last quarter, +320bps) to hold against persistent mix/ramp dilution, 12-18 month optical lead times and memory inflation. The deliberate fixed-networks drag (-13%) should continue. The bull case hinges on the AI/cloud order momentum — and whether the reaffirmed EUR2.0-2.5bn profit range gets a formal lift this time.
Tesla's Margin Inflection Meets a $25B Cash-Burn Bet
Tesla (TSLA) is confirmed to report earnings on Wednesday, July 22, 2026 at approximately 4:05 PM ET. Consensus sits at $0.53 per share on revenue of $25.36 billion—good for 12.7% year-over-year growth—while the Earnings Whisper ® number is a touch higher at $0.55. Sentiment is constructive, with 58.5% expecting a beat, yet the setup is far from clean: short interest has jumped 20.6% since last quarter and overall estimates have been revised lower, even as the stock has drifted 1.5% higher post-earnings to sit 8.7% below its $417.18 200-day moving average. Option traders are pricing in a 7.1% move versus a 4.3% recent average, and Friday's tape flagged notable buying of 35,552 of the $150.00 puts expiring July 24.
The crux is a real operating inflection running headlong into a deliberate cash-consuming CapEx cycle. Auto margins ex-credits have climbed four straight quarters to 19.2%, demand is resurgent (EMEA France/Germany +150% q/q, highest Q1 backlog in two years), FSD paid users reached ~1.3M, and regulatory/product catalysts turned concrete—Netherlands FSD approval, EU-wide expected, Robotaxi now in three cities. But management is guiding to negative free cash flow for the rest of 2026 as CapEx guidance balloons past $25B, and Q1's margin beat leaned on ~$230M in warranty/tariff one-timers with energy similarly flattered by >$250M. Watch whether the margin trajectory holds without one-offs and how aggressively the cash-burn narrative firms up.
Intel Heads Into Q2 Print Riding Six Straight Beats and a Confidence Surge
Intel (INTC) is confirmed to report earnings on Thursday, July 23, 2026 at approximately 4:00 PM ET. The consensus sits at $0.21 per share on revenue of $14.42 billion—good for 12.1% year-over-year growth—while the Earnings Whisper number runs meaningfully higher at $0.29. Management guided to roughly $0.20 on revenue of $13.80 to $14.80 billion. Sentiment is decidedly bullish, with 82.4% expecting a beat. Short interest has crept up 7.1% since last quarter, yet the stock has drifted 15.6% higher off its post-earnings open and now sits a striking 48.4% above its $64.02 200-day moving average. Estimates have been revised higher into the print. Options traders are pricing in a 15.2% move versus a 9.9% average in recent quarters, and on Friday, July 10, notable buying hit 21,032 contracts of the $65.00 put expiring August 28.
The setup here is a company that has flipped the narrative from survival to scaling supply. Last quarter delivered a sixth consecutive beat that got bigger—revenue $1.4B above midpoint, gross margin at 41% (~650bps ahead of guide), and EPS of $0.29 against a breakeven bar. Management explicitly raised the server CPU outlook to double-digit unit growth and stacked on marquee wins: the TerraFab partnership with SpaceX/xAI/Tesla, Google as a named multi-year LTA customer, Xeon 6 in NVIDIA's DGX Rubin, and the accretive Fab 34 buyback. Watch the offsets: Q2 gross margin was guided down to 39% on early 18A ramp mix, OpEx is likely to exceed the $16B target, and 2H PC demand plus rising memory/substrate costs remain the key risks. With the stock stretched and options pricing a big swing, the bar is high—but momentum and estimate revisions are firmly on Intel's side.
GOOGL: Cloud Acceleration Meets a CapEx Bill Coming Due
Alphabet (GOOGL) is confirmed to report earnings on Wednesday, July 22, 2026 at approximately 4:00 PM ET. The Street sits at $2.87 per share, but the Earnings Whisper ® number is a full 23 cents higher at $3.10, and sentiment is decidedly bullish with 79.6% expecting a beat. That optimism comes despite a 10.0% rise in short interest since last quarter and a 7.3% drift lower from the post-earnings open, leaving the stock 7.9% above its 200-day moving average of $321.27. Estimate revisions have trended higher into the print. Options traders are pricing in a 6.8% move versus a 3.8% average in recent quarters, and on July 15 we flagged notable buying of 60,326 of the $415.00 calls expiring August 21.
The setup: Cloud is the whole story. Last quarter revenue growth accelerated to +63% (>$20B) with backlog nearly doubling to $462B and operating margin climbing to 32.9%—the fourth straight quarter of expansion. Search reaccelerated to +19% and paid subs hit 350M, all backed by the highest-confidence management tone in the data set. The offset is spending: FY26 CapEx was raised to $180-190B, FCF fell to $10.1B as quarterly CapEx surged to $35.7B, and FY27 is guided 'significantly' higher—keeping depreciation and energy pressure on the P&L. Watch whether cloud momentum and the record backlog continue to justify the escalating outlay, plus the Wiz margin headwind, a fading FX tailwind, and persistent compute supply constraints.
ServiceNow Q2: AI Momentum vs. Margin Skepticism
ServiceNow (NOW) is confirmed to report earnings on Wednesday, July 22, 2026 at approximately 4:10 PM ET. The consensus earnings estimate is $0.86 per share on revenue of $3.92 billion, representing 21.9% year-over-year revenue growth, and the Earnings Whisper® number is $0.90 per share. Company guidance called for revenue of roughly $3.82 billion. Investors are bearish heading into the print, though 69.0% still expect a beat. Notably, short interest has more than doubled (up 107.9%) since last quarter even as the stock has drifted 18.3% higher off its post-earnings open, leaving it 20.0% below its 200-day moving average of $129.10. Overall estimates have been revised lower since last report. Option traders are pricing in a 12.8% move versus a 10.2% recent-quarter average, and we flagged notable buying of 15,010 $60.00 puts (expiring July 24) on July 16.
The setup mirrors last quarter's tension: genuinely improving fundamentals against margin skepticism. Q1's beat-and-raise was almost entirely Armis-driven (125bp of the +$205M subscription raise), with the organic full-year guide held flat and margins stepping down across the board (operating margin to 31.5% from 32%, FCF to 35%) on integration costs — the reason the stock fell ~12% after hours. The bull case is AI monetization: NowAssist run-rate jumped to $1.5B from a prior $1B target, new logo ACV growth accelerated past 50% YoY, and 50% of net new business is now non-seat-based. Watch two things this print: whether AI ACV keeps compounding to justify the M&A pace, and whether the flagged ~75bp Middle East on-prem timing headwind slipped into Q2. Q2 operating margin is guided to just 26.5%, so any organic revenue reacceleration is what convinces the bears.
AMC's Box-Office Recovery Finally Hits the P&L — Arena One Is the Wild Card
AMC Entertainment (AMC) is confirmed to report earnings on Monday, July 20, 2026 at approximately 7:40 AM ET. The consensus calls for breakeven results on revenue of $1.48 billion, up 5.9% year-over-year, with the Earnings Whisper number sitting slightly ahead at $0.03 per share. Sentiment is decidedly bullish, with 76.2% of investors expecting a beat, and the setup supports it: short interest has collapsed 40.9% since last quarter, estimates have been revised higher, and the stock has drifted up 16.2% from its post-earnings open to trade 6.4% above its $1.82 200-day moving average. Options traders are bracing for a 34.3% swing versus a recent-quarter average move of just 2.6% — a notable disconnect — and Friday's buying of 16,440 of the $1.50 puts expiring August 21 is worth watching for downside hedging.
The real story is whether last quarter's inflection holds. Q1 delivered $38.3M in adjusted EBITDA (up $96M YoY, best Q1 since 2019), revenue crossed $1B for the first time since 2019, and contribution margin per patron hit a record $15.19 on a +22% North American box office. Watch for early read-through on Arena One, the new live-concert product that launched across 300+ US theaters in June at near-zero upfront capex — the first genuinely new revenue line in years. The balance sheet is materially de-risked (LT debt down to ~$3.9B, 2027 maturities refinanced to 2031), but AMC is still not full-year free-cash-flow positive and remains hostage to the 2026/2027 slate delivering as promised. Guidance was reaffirmed, not broadly hiked — so any raise to the +$500M–$1.2B box-office range would be the bullish catalyst the setup is pricing for.
IBM: Improving Fundamentals, But Chart and Short Interest Flash Caution Into Q2
IBM (IBM) is confirmed to report earnings on Wednesday, July 22, 2026 at approximately 4:10 PM ET. The Street is looking for $3.00 per share on revenue of $17.59 billion (up 3.6% YoY), while the Earnings Whisper® number sits a touch lower at $2.93. Sentiment is modestly bullish—54.2% expect a beat and estimates have been revised higher since last quarter—but the tape tells a more cautious story: short interest has jumped 47.2%, and the stock has drifted 8.4% lower from its post-earnings open to sit a striking 22.4% below its 200-day moving average of $273.99. Options traders are bracing for a 7.1% move, roughly in line with the 6.9% average of recent quarters, and we'd flag the notable July 14 buying of 4,373 August $200 puts.
The fundamental setup remains constructive. Last quarter delivered a clean beat with software ARR of $24.6B (+10%), a raised software guide to 10%+, data lifted to low-20%+ on an early Confluent close, and genuine inflections in Red Hat (reaccelerating to 10%) and Consulting signings (+6% after a long slump). The key tension: management deliberately held—not raised—the full-year revenue and FCF guide despite the strong start, citing macro uncertainty. Watch Q2 margin expansion, which is guided to just ~50bps (vs 140bps in Q1) as Confluent dilution bites, plus any read on infrastructure softness and DRAM supply-chain pressure. With the stock deeply below trend and shorts piling in, this is an improving-but-prudent name where the fundamentals and the chart are still at odds.
GEV: Momentum Building Into Q22026 Print — All Eyes on the Next Guidance Raise
GE Vernova (GEV) is confirmed to report earnings on Wednesday, July 22, 2026 at approximately 6:30 AM ET. The consensus stands at $3.16 per share on revenue of $10.77 billion — 18.2% year-over-year growth — while the Earnings Whisper number runs meaningfully higher at $3.47. Sentiment is constructive, with 69.6% of investors expecting a beat and overall estimates revised upward since last quarter, though short interest has jumped 60.3% into the print. The stock sits 29.6% above its $816.14 200-day moving average after drifting 1.7% lower from last quarter's post-earnings open. Option traders are pricing a 10.9% move versus a 6.4% recent average, and on July 16 there was notable buying of 1,677 of the $840 puts expiring September 18, 2026.
The setup here is about whether management extends an already-strong momentum story. Last quarter delivered a broad guidance raise across revenue ($44.5-45.5B), adjusted EBITDA margin (12-14%), and free cash flow ($6.5-7.5B), with backlog swelling to $163B and the $200B target pulled forward to 2027. Gas gigawatts under contract accelerated to 100GW with pricing up 10-20 points per kW, electrification orders jumped 86% (data center orders alone topped all of FY25), and the newly closed Prolec acquisition is already accretive at >20% margins. The lone drag remains wind — a contained ~$400M FY26 loss — alongside a steady $250-350M tariff impact. With no material cuts and catalysts stacking up, the key question is simply how much higher the guide goes.
Domino's Faces a Softening Consumer Test Ahead of Q1 Print
Domino's Pizza (DPZ) is confirmed to report earnings on Monday, July 20, 2026 at approximately 6:05 AM ET. The consensus earnings estimate is $4.11 per share on revenue of $1.18 billion, representing 3.0% year-over-year revenue growth, and the Earnings Whisper number is $3.98 per share. Investors are bearish heading into this release, with only 44.4% expecting a beat, and the skepticism shows up in the tape: short interest has climbed 13.2% since last quarter, the stock has drifted 5.6% lower from its post-earnings open, and it now sits 14.5% below its 200-day moving average of $376.86. Overall estimates have been revised lower since the last report. Option traders are pricing in a 7.0% move versus the 3.3% average of recent quarters, though we did note some notable buying of 909 contracts of the $360.00 call expiring August 21, 2026 on Friday, July 17.
The setup is defined by last quarter's negative inflection. US same-store sales decelerated hard to +0.9% (from +3.7% in Q4), delivery turned negative, and international slipped to -0.4%, prompting management to cut guidance on every line — US comps, international, global retail sales, and operating income growth. The culprits were a consumer at COVID-low sentiment, intensified competitive value-matching, and margin pressure from labor, food, and insurance. The bull case (roughly 450 competitor closures in 2026, continued store growth, the new AI Pizza Tracker app and DomOS rollout, and a stepped-up buyback with ~$1.29B remaining) remains intact but is increasingly back-half dependent. Watch whether US comps stabilize and whether the reaffirmed low-single-digit guide holds — another cut would confirm the softening trend.
TXN Enters Q2 With Broad Acceleration Intact — 2H Sustainability Is the Swing Factor
Texas Instruments (TXN) is confirmed to report earnings on Wednesday, July 22, 2026 at approximately 4:00 PM ET. The Street is looking for $1.91 per share on revenue of $5.22 billion — a robust 17.4% year-over-year top-line gain — but the whisper number sits higher at $2.01, implying the market wants a beat toward the upper end of management's $1.77-$2.05 EPS and $5.00-$5.40 billion revenue guidance. Sentiment is decidedly bullish, with 81.3% expecting a beat, short interest down 5.0% since last quarter, and estimates revised higher across the board. The stock has drifted up 9.1% since the last print and now trades 28.4% above its $221.24 200-day average. Options traders are bracing for an 11.6% move (versus a 10.4% recent average), and we flagged notable buying of 7,144 of the $400 calls expiring July 31 on July 9 — a sign of positioning for upside.
Coming off a genuine Q1 inflection — revenue up 9% QoQ/19% YoY, gross margin jumping 210 bps to 58%, pricing flat rather than the modeled 2-3% decline, and standout strength in industrial (+30% YoY), data center (~90% YoY), and comms — the setup is strong but not without watch items. Automotive remains the laggard (mid-single YoY, China down sequentially) and management itself has repeatedly cautioned that 2025 was a 'false start' with a decelerating second half. That makes the 2H FY26 outlook, not the Q2 beat, the key debate. Watch for updates on the Silicon Labs acquisition timeline, data center socket ramps into 2H, and any confirmation of price increases — all of which would extend the bull case beyond a single quarter.
CHS: Deleveraging Story Intact, But Volumes Are the Wildcard
Community Health Systems (CYH) is confirmed to report earnings on Wednesday, July 22, 2026 at approximately 4:15 PM ET. The consensus estimate is a loss of $0.18 per share on revenue of $2.90 billion, a decline of 7.4% year-over-year, and the Earnings Whisper® number is a loss of $0.22 per share — a wider miss risk that keeps us cautious. Investors are bearish going into the release, though a split 50.0% still expect a beat. Short interest has climbed 7.3% since last quarter even as the stock has drifted 15.0% higher off its post-earnings open to sit 3.0% above its $3.20 200-day moving average. Overall estimates have been revised lower, and with an average 15.9% swing in recent quarters, expect fireworks either way.
The key watch item is whether Q1's broad volume softness was a one-off or the start of a trend. Same-store adjusted admissions fell -0.5% and inpatient -1.3% last quarter, reversing 2025's stabilization, with surgeries -2.2% and ED -2.8% dragging EBITDA down 17.8% YoY to $309M (10.4% margin). Management pinned the shortfall on temporary, back-half-weighted demand pressures and reaffirmed full-year EBITDA guidance of $1.34-$1.49B, so we need confirmation that the recovery is materializing. The bright spots remain intact: leverage improved to 6.5x, net debt is heading toward ~$9.3B post-Arkansas, quality scores jumped sharply, and cost control held (contract labor -11%). Watch for follow-through on the Georgia SDP contribution (~$25M EBITDA, mostly out-of-period), the closing of the Surgical Institute of Alabama acquisition, and any color on the MA AR buildup and managed-care denial pressures.
Bank Earnings Roar, Health Insurers Grind, and a Fuel Spike Clips United's Wings
If last week's earnings deluge had a single unifying pulse, it was the sound of Wall Street's trading and dealmaking machinery running red-hot. The money-center banks put on a clinic: JPMorgan posted $6.14 in EPS against a $5.59 consensus as equities revenues rocketed 86% year-over-year and management conceded it was "getting close to as good as it gets," while Bank of America nudged its net-interest-income guide to the top of its range and lifted its operating-leverage target on record fee results, closing the week up 2.7%. Citigroup logged its best quarterly revenue in a decade and upsized its buyback to $30 billion, with Jane Fraser declaring "Citi is back in the game," though the stock still slid 8% as investors balked at cards-related cost drag and conservative guidance. Morgan Stanley crossed the symbolic $10 trillion client-asset mark, raised its dividend 15%, and rode a record $6.3 billion equities quarter, while Goldman Sachs crushed estimates at $20.98 versus $14.47 expected on a 23% revenue surge. Even Wells Fargo, finally unshackled from its asset cap, grew revenue 9% and printed record investment-banking fees, though shares barely budged as persistent net-interest-margin compression from deliberate low-spread markets growth dominated the debate.
The healthcare and industrial names told a more nuanced, two-speed story. UnitedHealth and Elevance both extended turnaround narratives—UNH delivered a third straight guidance raise and doubled its buyback, and ELV closed out a nagging CMS risk-adjustment overhang with a second consecutive EPS hike—yet both remain shackled by loss-making Medicaid books and, in UNH's case, a commercial-cost recovery now slipping past 2027, which helped drag its shares nowhere despite the beat (ELV actually tumbled more than 10%). Johnson & Johnson raised guidance across sales, EPS, and margins on the strength of blockbuster launches like Tremfiya, but a stumble in its cardiovascular MedTech unit—Abiomed swung to a 2% decline after a disappointing UK trial—exposed a genuinely two-speed quarter. United Airlines rounded out the week as a cautionary reminder that macro shocks don't respect strong fundamentals: revenue jumped 16% with premium and corporate demand accelerating and 2027 margin conviction "never higher," but a mid-July fuel spike worth $1.12 in EPS forced management to narrow its full-year range and sent the stock down more than 8%. Across the board, the theme was clear—capital-markets muscle is carrying the tape, while insurers and industrials must grind through cost pressures and idiosyncratic soft spots to prove their momentum is durable.
The Earnings Whisper Grade and the Post-Earnings Announcement Drift (PEAD)
The S&P 500 is up approximately 1.8%, but the more than 100 stocks of companies that reported A+ earnings last quarter are up an average of 13.9% from their open following their earnings release. On the other hand, the 65 stocks with an Earnings Whisper Grade of F have fallen an average of 2.8%.
Netflix: Cleaner, Organic Story as WB Overhang Lifts; FY Guide Nudged Up
Netflix (NFLX) reported Q2 FY2026 (ended June 2026) earnings of $0.80 per share on revenue of $12.56 billion, essentially in line with the $0.79/$12.57B consensus but shy of the $0.84 Whisper — a 4.76% earnings miss even as revenue grew a healthy 13.37% year over year. Guidance for Q3 (approx. $0.82 EPS on $12.86B revenue) sits modestly below the $0.83/$13.02B Street view. Netflix remains the world's leading streaming service, with 222 million paid memberships across 190+ countries spanning TV, film and documentaries in a wide range of genres and languages.
The headline for us isn't the penny miss — it's the strategically cleaner setup. With the Warner Bros. acquisition overhang gone, management is back to a builders-not-buyers narrative, and the numbers support it: FY2026 reported revenue growth was effectively raised to 13-14%, the 31.5% operating margin target was reaffirmed, and Q2 buybacks hit a record $4.7B (~$27B still authorized). Newer initiatives are gaining real traction — the TF1 France partnership is off to a 'very promising' start, cloud games MAUs are up 11x since October, kids mobile engagement is +600% y/y, and Gen AI tooling now spans ~300 titles at meaningfully lower cost. Watch two offsets: FX-neutral growth decelerates from 12% to ~11% into Q3 (management pins this on last year's back-half weighting), and content amortization accelerating to ~10% raises the bar on converting spend into revenue. Net: a positive, tidier quarter with steady rather than newly bullish tone.
UNH's turnaround gains traction with third straight guidance raise
UnitedHealth Group (UNH) delivered a decisive beat for the quarter ended June 2026, posting earnings of $6.38 per share on revenue of $112.03 billion, blowing past the $4.94 consensus (and the $5.00 Whisper) by nearly 28% even as revenue was essentially flat, up 0.37% year-over-year. More importantly, management raised FY26 guidance for the third consecutive quarter, now to $19.50-$20.00 per share from the prior floor of $18.25 and well above the $18.39 Street estimate. CEO Stephen Hemsley framed the results as reflecting "continuing progress in our work to simplify how we operate, improve both affordability and the health care experience," and the notably more confident tone backs that up. UNH remains a health care and well-being company operating two complementary businesses across insurance (UnitedHealthcare) and services (Optum).
The raise is broad-based: UnitedHealthcare FY26 operating earnings lifted to at least $12B, OptumHealth to at least $2.2B, MA margins now seen finishing above 3% as Medicare trend runs below the initial ~10% assumption, and MCR improving to 88.1%. Capital return re-accelerated with buybacks doubled to at least $5B and the dividend raised to $9.28/share, and management reaffirmed the 13-16% long-term EPS growth algorithm off this new base. The one persistent drag worth watching: commercial cost trend has worsened to "modestly above 11% and rising" on No Surprises Act IDR abuse and coding intensity, pushing commercial margin recovery to the 7%+ target beyond 2027. Medicaid also stays loss-making (-1.0% to -1.7%). Net read: a genuine, quantified turnaround firmly in the improving camp, tempered only by the commercial timeline slip.
TSMC Crushes Q2 as AI Demand Fuels Blowout Guidance
Taiwan Semiconductor ADR (TSM) delivered a decisive beat for the second quarter ended June 2026, posting earnings of $4.31 per share on revenue of $40.20 billion. That topped the consensus estimate of $3.87 per share and the $3.98 Earnings Whisper number, while revenue edged past the $39.63 billion Street view. The bottom line came in 8.29% ahead of expectations, and revenue surged 33.69% year-over-year, underscoring the strength of the underlying demand story.
The real headline is guidance: management now expects third quarter revenue of $44.6 billion to $45.8 billion, well above the $42.6 billion consensus for the period ending September 30, 2026. As the dominant foundry manufacturing, testing, and packaging integrated circuits and semiconductor devices, TSMC's outsized outlook signals sustained momentum and reinforces its position at the center of the ongoing chip cycle. We view this print and the raised bar as a clear positive.
ASML: AI Supercycle Confirmed as Full-Year Guide Raised Again
ASML Holding NV (ASML) reported earnings of $8.81 per share on revenue of $10.84 billion for the second quarter ended June 2026, comfortably clearing the $7.98 consensus and the $8.32 Whisper number—a 5.89% beat as revenue jumped 24.24% year-over-year. More important than the print is the guide: management now sees 2026 revenue of $49.10-$51.38 billion, up sharply from its prior $42.4-$47.1 billion range and well above the $45.35 billion consensus, with Q3 pegged at $12.56-$13.70 billion versus a $11.34 billion Street estimate. CEO Christophe Fouquet credited above-guidance Q2 net sales of €9.3 billion and a 54.0% gross margin to stronger-than-expected Installed Base Management sales, adding that accelerating AI investment is driving demand for advanced Logic and Memory chips and pushing customers to speed up capacity expansion. ASML remains the critical lithography supplier to the semiconductor industry, with products including TWINSCAN, PAS 5500, and Optics.
This is the second consecutive material full-year raise (€34-39B to €43-45B in two quarters) alongside a lifted 54-56% gross-margin band, and the breadth is what stands out: memory system sales now guided +75%, EUV +45%, advanced logic +25%, and even non-EUV +25%, reversing the prior 'flattish' view. Forward visibility is the strongest in years—2027 low-NA EUV is nearly fully order-covered at ~85 units (+30%) with a further +30% for 2028 already under investigation, and Intel Foundry's public adoption of ASML High-NA is the clearest high-volume validation to date. Value-based pricing conversations are now active given tight supply. The offsets are minor and well-telegraphed: China normalizes to ~20% of 2026 sales, High-NA stays margin-dilutive until 2028-2029 volumes, and the binding constraint has shifted from demand to supply and customer fab readiness. Net: momentum is strongly improving and the AI capex cycle is now demand-driven, not hoped-for.
ISRG Beats on Margins, But US Procedure Growth Cools
Intuitive Surgical (ISRG) reported Q2 FY26 earnings of $2.80 per share on revenue of $2.89 billion, topping the $2.50 consensus and the $2.64 Whisper by 6.06%, with revenue up 18.54% year-over-year. "We are pleased with company performance this quarter, which reflects the strength of our portfolio – from da Vinci and Ion to our growing digital solutions," said CEO Dave Rosa, reiterating a focus on better patient outcomes, improved care experiences, lower costs, and broader access to minimally invasive care. Intuitive designs, manufactures, and markets da Vinci Surgical Systems and related instruments and accessories.
The headline beat masks a softening demand story. US da Vinci procedure growth decelerated to 12% from 14% in Q1 and 16% a year ago, pressured by deferrable/benign cases, expiring ACA premium subsidies, and continued GLP-1 drag on bariatrics. Management held the full-year procedure guide at 13.5-15.5% but now steers to "closer to the midpoint" – a de facto walk-back from Q1's raise cadence – and struck a more measured tone. China remains a headwind (only 2 placements, DV5 still not cleared on the mainland). Offsetting this: non-GAAP gross margin guidance was lifted to 68-69%, H1 free cash flow jumped 71% to $1.8B, placements rose 18%, and new catalysts emerged (GI endoluminal robot 510(k) filing, Extended Use Program, DV5 clearance in India, favorable Japan reimbursement, and record ASC placements). Net: healthy margins and fresh catalysts keep this from turning sharply negative, but demand momentum has clearly eased.
